Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7311 | 1304 | 52.0 | 95% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
232 | 19686 | TAMOXIFEN//AROMATASE INHIBITORS//ANASTROZOLE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AIB1 | Author keyword | 66 | 83% | 3% | 38 |
2 | STEROID HORMONES SECT | Address | 65 | 76% | 3% | 45 |
3 | RIP140 | Author keyword | 35 | 74% | 2% | 26 |
4 | SRC 3 | Author keyword | 31 | 74% | 2% | 23 |
5 | NUCLEAR RECEPTOR COACTIVATOR | Author keyword | 21 | 85% | 1% | 11 |
6 | STEROID RECEPTOR COACTIVATOR 3 | Author keyword | 15 | 88% | 1% | 7 |
7 | COACTIVATOR | Author keyword | 13 | 18% | 5% | 65 |
8 | SRC 1 | Author keyword | 13 | 38% | 2% | 27 |
9 | COREPRESSOR | Author keyword | 9 | 20% | 3% | 38 |
10 | STEROID RECEPTOR COACTIVATOR 1 | Author keyword | 8 | 44% | 1% | 14 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AIB1 | 66 | 83% | 3% | 38 | Search AIB1 | Search AIB1 |
2 | RIP140 | 35 | 74% | 2% | 26 | Search RIP140 | Search RIP140 |
3 | SRC 3 | 31 | 74% | 2% | 23 | Search SRC+3 | Search SRC+3 |
4 | NUCLEAR RECEPTOR COACTIVATOR | 21 | 85% | 1% | 11 | Search NUCLEAR+RECEPTOR+COACTIVATOR | Search NUCLEAR+RECEPTOR+COACTIVATOR |
5 | STEROID RECEPTOR COACTIVATOR 3 | 15 | 88% | 1% | 7 | Search STEROID+RECEPTOR+COACTIVATOR+3 | Search STEROID+RECEPTOR+COACTIVATOR+3 |
6 | COACTIVATOR | 13 | 18% | 5% | 65 | Search COACTIVATOR | Search COACTIVATOR |
7 | SRC 1 | 13 | 38% | 2% | 27 | Search SRC+1 | Search SRC+1 |
8 | COREPRESSOR | 9 | 20% | 3% | 38 | Search COREPRESSOR | Search COREPRESSOR |
9 | STEROID RECEPTOR COACTIVATOR 1 | 8 | 44% | 1% | 14 | Search STEROID+RECEPTOR+COACTIVATOR+1 | Search STEROID+RECEPTOR+COACTIVATOR+1 |
10 | TIF2 | 7 | 56% | 1% | 9 | Search TIF2 | Search TIF2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AIB1 | 87 | 67% | 6% | 78 |
2 | SRC 1 | 48 | 61% | 4% | 51 |
3 | SRC 3 | 41 | 87% | 2% | 20 |
4 | N COR | 40 | 24% | 11% | 145 |
5 | RECEPTOR INTERACTING PROTEIN 140 | 32 | 78% | 2% | 21 |
6 | STEROID RECEPTOR COACTIVATOR 3 | 27 | 78% | 1% | 18 |
7 | CO REPRESSOR | 26 | 17% | 10% | 134 |
8 | RECEPTOR COACTIVATOR AIB1 | 25 | 70% | 2% | 21 |
9 | TRANSCRIPTIONAL COACTIVATOR | 25 | 15% | 12% | 154 |
10 | INTERACTING PROTEIN 140 | 22 | 67% | 2% | 20 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family | 2009 | 138 | 187 | 66% |
Nuclear Receptor Coactivators: Master Regulators of Human Health and Disease | 2014 | 7 | 66 | 68% |
Combinatorial control of gene expression by nuclear receptors and coregulators | 2002 | 924 | 95 | 47% |
Steroid Receptor Coactivator (SRC) Family: Masters of Systems Biology | 2010 | 75 | 83 | 64% |
Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation | 2007 | 221 | 92 | 38% |
Steroid receptor coactivators 1, 2, and 3: Critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy | 2012 | 33 | 121 | 55% |
Review of the in vivo functions of the p160 steroid receptor coactivator family | 2003 | 291 | 85 | 69% |
The in vivo role of nuclear receptor corepressors in thyroid hormone action | 2013 | 15 | 31 | 68% |
Nuclear receptor coregulators: modulators of pathology and therapeutic targets | 2012 | 51 | 80 | 36% |
Deconstructing repression: evolving models of co-repressor action | 2010 | 190 | 178 | 24% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STEROID HORMONES SECT | 65 | 76% | 3.5% | 45 |
2 | LIGAND TRANSCRIPT | 5 | 45% | 0.7% | 9 |
3 | LMCB | 4 | 29% | 1.0% | 13 |
4 | UC DAVIS CANC BASIC SCI | 4 | 56% | 0.4% | 5 |
5 | BIOL MOL OPTOSIS | 3 | 50% | 0.4% | 5 |
6 | ENDOCRINE ONCOL GRP | 3 | 50% | 0.4% | 5 |
7 | BAYLOR PROSTATE CANC SPECIALIZED PROGRAMS EXC | 3 | 100% | 0.2% | 3 |
8 | UCDMC 3 | 3 | 100% | 0.2% | 3 |
9 | PENN DIABET | 2 | 19% | 0.8% | 10 |
10 | CHONGQING NEUROBIOL | 2 | 14% | 0.8% | 11 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000177977 | ESTROGEN RECEPTOR VARIANTS//JC HEUSON CANCEROL MAMMAIRE//SERV HISTOL CYTOL EXPT |
2 | 0.0000143291 | ESTROGEN RECEPTOR BETA//ER BETA//RECEPTOR BIOL SECT |
3 | 0.0000131560 | RESISTANCE TO THYROID HORMONE//THYROID HORMONE RECEPTOR//V ERBA |
4 | 0.0000123725 | RETINOYLATION//RETINOBENZOIC ACID//RXR |
5 | 0.0000113507 | MED12//MEDIATOR COMPLEX//MED19 |
6 | 0.0000110800 | MYST//MOZ//HISTONE ACETYLTRANSFERASE |
7 | 0.0000101196 | SERAMS//MATH CHEM//ESTROGEN RECEPTOR LIGANDS |
8 | 0.0000094909 | ANDROGEN RECEPTOR//ANDROGEN INSENSITIVITY SYNDROME//ANDROGEN INSENSITIVITY |
9 | 0.0000094634 | TR4//GERM CELL NUCLEAR FACTOR//GCNF |
10 | 0.0000094158 | RETINOBLASTOMA BINDING PROTEIN 6//SAFB//RBBP6 |